orforglipron vs ATTAIN — genuinely asking which matters more
ACHIEVE. That is the whole post, but I will justify it. Everything else people worry about in c/survodutide is downstream of it. Titration speed, early fullness, the endless dose arguments — most of it resolves if you sort ACHIEVE out first, and almost nobody does. I say this having got it wrong for 9 months. My eGFR…
Not convinced. The evidence does not support that reading.
availability speculation must be flaired Speculation
oral non-peptide agonist is ACHIEVE, no food restrictions